Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications
Open Access
- 1 October 2026
- journal article
- review article
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 18 (4) , e70510
Abstract
The field of Alzheimer's disease (AD) research has seen major advances in understanding manifestations of AD‐related neuropsychiatric symptoms (NPS), including recent addition of NPS to the 2024 National Institute of Aging–Alzheimer's Association (NIA‐AA) clinical staging framework. This focused review highlights key publications (49 in 2024; 28 in 2025) indexed in MEDLINE examining AD‐related NPS, in alignment with the Scale for the Assessment of Narrative Review Articles guidelines. Data were thematically organized across NIA‐AA clinical stages, with emphasis on measurement, diagnosis, and biomarker‐cognition correlates of AD‐related NPS. Together, these findings can inform future research and clinical practice through enhanced understanding of AD‐related NPS and their relationships with pathology and clinical outcomes. Finally, three key priorities were identified for future research: (1) incorporating sex/gender and ethnocultural diversity; (2) integrating NPS assessment with cognitive, fluid, and neuroimaging biomarkers; and (3) including perspectives of individuals with lived experience to support personalized NPS management.Keywords
This publication has 87 references indexed in Scilit:
- Neuropsychiatric symptom phenotypes for early detection of risk in older adultsAlzheimer's & Dementia, 2025
- Defining the contributions of tau pathology in the amygdala to increasing depressive symptoms in agingAlzheimer's & Dementia, 2025
- Late‐life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individualsAlzheimer's & Dementia, 2025
- Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's diseaseAlzheimer's & Dementia, 2025
- Change in Depressive Symptoms and Longitudinal Regional Amyloid Accumulation in Unimpaired Older AdultsJAMA Network Open, 2024
- Psychosis in Alzheimer Disease and Elevations in Disease-Relevant BiomarkersJAMA Psychiatry, 2024
- Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early‐ and late‐onset Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia‐free older adultsAlzheimer's & Dementia, 2024
- Wrist‐worn actigraphy in agitated late‐stage dementia patients: A feasibility study on digital inclusionAlzheimer's & Dementia, 2024